Innovation

NR-6-R Cells for the Study of FGFs

University of Nebraska System: University of Nebraska Medical Center
posted on 08/24/2010

Fibroblast Growth Factors (FGFs) and fibroblast growth factor receptors together form a highly conserved signaling system that is used in both developmental and physiological processes of the adult. The 18 known FGFs are involved in the development and homeostasis of virtually every human tissue. Given its ubiquity, establishing FGF activity is a critical step in understanding a wide variety of biological processes. Scientists at the University of Nebraska Medical Center have substantial expertise in assaying FGFs. Specifically, the isolation of NR-6-R cells and their use as a highly sensitive bioassay for FGFs was first reported by Dr. Angie Rizzino at UNMC within the Eppley Institute for Research in Cancer and Allied Diseases. NR-6-R cells are a versatile and sensitive tool for determining FGF activity and have been employed in a variety of assays. UNeMed is currently offering licensing opportunities for the NR-6-R cells produced in Dr. Rizzino’s laboratory. The cells can be employed in a wide variety of assays, such as soft agar assays and proliferation assays, to identify and measure FGF activity.


Innovation Details

IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Matt Boehm at University of Nebraska System: University of Nebraska Medical Center for more information.

Request more info via email request more info
People

Case Manager:

Matt Boehm Matt Boehm

Innovations (9)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

8,793 members 16,677 innovations 159 organizations

Browse

Alan Thomas, Director, UChicagoTech

"The iBridge Network has opened up new avenues for innovations at UChicagoTech. Relationships between researchers from other universities or industry can be built and strengthened, while investors can find new technologies to advance. "  read more...